CD4 and breast carcinoma: Similar to clinical breast cancers (Savas et al., 2016) and consistent with previous reports of triple‐negative breast cancer growth in HIS mice (Wang et al., 2018), CD4+ T cells were the major infiltrating TIL subpopulation, with CD8+ T cells accounting for ~ 20–30%.